NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » Analysis » Four emerging technologies with the potential to improve MS treatment options » rebismart_789x473_tcm1494_125258

Four emerging technologies with the potential to improve MS treatment options

NS Medical Devices is using cookies

Merck’s electronic RebiSmart autoinjector device (Credit: Merck)

Related Article

Biggest players in the global wound care market

RECOMMENDED COMPANIES

MOST READ

Scopio Labs gets FDA nod for digital bone marrow aspirate application

Viz.ai, NICO collaborate on improving intracerebral hemorrhage outcomes

Outset Medical and U.S. Renal Care partner to expand home haemodialysis in US

FDA classifies Boston Scientific’s recall of Obsidio Embolic as most serious

Xstim secures FDA approval for spine fusion stimulator

Recommended Whitepaper